potential risks

Review of Investigator Qualifications: Verify GCP training and experience

Protection of Vulnerable Populations: Scrutinize consent process and trial design for pediatric, geriatric, or cognitively impaired subjects

Refer to your site’s SOPs for IRB submissions for process consistency and compliance.

IRB Composition and Independence:

Per ICH-GCP and CDSCO guidelines, an IRB must be multidisciplinary and include:

• At least five members with diverse backgrounds
• One member from a non-scientific area (e.g., legal, ethics)
• One member unaffiliated with the institution (community representative)
• At least one woman

This diversity ensures impartiality, community perspective, and robust ethical deliberation.

IRB Review Types:

IRBs conduct reviews based on study complexity and risk level:

• Full Board Review: Required for studies with greater than minimal risk
• Expedited Review: For minimal-risk studies or minor amendments
• Exempt Review: Reserved for specific categories defined under regulatory frameworks

The type of review determines documentation requirements and timelines.

IRB Submission Requirements:

Investigators must submit a complete application package including:

• Study protocol and synopsis
• Informed Consent Form (ICF) and translations
• Investigator’s Brochure (IB)
• PI’s CV and GCP training certificate
• Case Report Forms (CRFs), recruitment materials
• Insurance certificate (if applicable)
• Institutional cover letter and EC fee receipt (if applicable)

IRB review timelines and formats may vary by country or institution. Best practices are available via StabilityStudies.in.

IRB Approval Letter and Conditions:

Following review, the IRB may:

• Approve the study without modifications
• Request clarifications or amendments before approval
• Reject the study due to ethical or scientific concerns

The IRB approval letter will include conditions such as submission of safety reports, re-approvals for long studies, and prior approval for amendments.

Ongoing Interaction with IRBs:

IRB oversight continues throughout the study. Investigators are required to:

• Submit annual status reports or renewals for continuing review
• Report protocol deviations, serious adverse events (SAEs), or unanticipated risks
• Obtain prior approval for protocol amendments
• Notify IRB of trial closure with final report

All IRB communications must be documented in the Investigator Site File (ISF) and audit-ready per GMP documentation expectations.

IRB vs Ethics Committee (EC):

Though used interchangeably, IRBs and ECs differ slightly based on geography:

• IRB: Common term in the U.S. under FDA oversight
• EC: Term used in India, EU, and other regions

Both function similarly and adhere to ICH-GCP principles, but documentation and composition requirements may vary slightly.

Training and Working with IRBs:

Investigators and site teams must be trained on:

• IRB submission processes
• Timelines and documentation standards
• Responding to IRB queries
• Maintaining communication logs and audit trails

Refer to validation master plans and sponsor SOPs for IRB collaboration guidance.

Conclusion:

Institutional Review Boards serve as ethical gatekeepers in clinical research, ensuring participant safety and study integrity. Their oversight spans from study initiation to completion, requiring ongoing interaction and compliance from investigators. By understanding IRB roles, submission expectations, and documentation requirements, clinical research professionals can contribute to ethically sound and regulation-compliant trials.